2nd International Conference on Fostering Interdisciplinary Research In Health Sciences (ICFIRHS) 2019 (01-May-2019)        |

Journal :   Research Journal of Pharmacy and Technology

Volume No. :   11

Issue No. :  4

Year :  2018

Pages :   1407-1412

ISSN Print :  0974-3618

ISSN Online :  0974-360X


Registration

Allready Registrered
Click to Login

Targeted Cancer Therapy: Promises and Reality



Address:   Amy Elizabeth Jaibu1, Dr. R. Shanmuga Sundaram2*, Krishnaveni. K1, Sambathkumar R3
1Department of Pharmacy Practice, J. K. K.Nattraja College of Pharmacy, Kumarapalayam-638183, Tamil Nadu, India.
2Professor and Vice Principal, Department of Pharmacology, J. K. K. Nattraja College of Pharmacy, Komarapalayam-638183, Namakkal District, Tamilnadu, India.
3Department of Pharmaceutics, J. K. K. Nattraja College of Pharmacy, Kumarapalayam-638183, Tamil Nadu, India.
*Corresponding Author
DOI No: 10.5958/0974-360X.2018.00263.9

ABSTRACT:
Over the past decade of years, targeted therapies which include monoclonal antibodies (mAbs) and small molecule inhibitors have extensively changed the treatment patterns of cancer even though conventional cytotoxic chemotherapy remains the treatment of choice for many malignancies. The objective of this review is to analyse the available targeted cancer therapies in the market. Most of the standard chemotherapies act on both rapidly dividing normal as well as cancerous cells, whereas targeted therapies acts on specific molecular targets that are associated with cancer and thereby offer the prospect of more effective cancer treatment, with fewer side effects. As more persons are diagnosed with cancer and as these patients live longer, primary care physicians will increasingly provide care for patients who have received targeted cancer therapy. Unfortunately, many of the more recent targeted therapies are not as successful over time.
KEYWORDS:
Targeted cancer therapy, Chemotherapy, Cancer, Monoclonal antibodies. Small molecule inhibitors.
Cite:
Amy Elizabeth Jaibu, R. Shanmuga Sundaram, Krishnaveni. K, Sambathkumar R. Targeted Cancer Therapy: Promises and Reality.Research J. Pharm. and Tech 2018; 11(4): 1407-1412.
[View HTML]     



Visitor's No. :   683738